- 100 Springdale Rd Ste A3 #157 Cherry Hill, New Jersey 08003 United States
- info@kenx.org
- 858 649 3251
This session is the preview. The full hands-on workshop, the Reinvention Lab Mini-Lab, runs the morning of October 8 in Philadelphia, Day 2 of KENX MedTech Validation University. August 19 shows you the framework. October 8 is where you apply it to your own organization.
CSV was built for on-premise software, waterfall development, and paper-based quality systems. That framework delivered value in its time. The world it was designed for no longer exists.
Free to attend. Can't join live? Register and we'll send the recording.
The join link is on its way to your inbox. Add it to your calendar for Wednesday, August 19 at 11:00 AM EDT — and if you can't make it live, the recording comes to the same address.
While you wait: the Mini-Lab on October 8 is where this becomes hands-on work on your own organization's decisions.
See the Mini-Lab on the agenda
ProcellaRX is a strategic consulting and digital validation firm specializing in computer software assurance (CSA), computerized system validation (CSV), AI governance, and regulatory compliance for life sciences, pharmaceutical, biotech, and medical device companies.
Dori created the Decision Quality Intelligence (DQI) Framework and founded the Reinvention Lab to rebuild how regulated organizations make quality decisions. She facilitates the Mini-Lab in Philadelphia on October 8.
Today, organizations deploy cloud-native SaaS platforms updated weekly. AI and machine learning are moving from research curiosities into production-quality workflows. Regulators have clearly signaled that least-burdensome, risk-based approaches are not merely acceptable — they are preferred. And yet many validation practices remain anchored to an era that is over.
The Reinvention Lab was founded on the conviction that this moment demands more than incremental adjustment. Join Dori Gonzalez-Acevedo for a conversation about what the Lab is, why it exists, and why this industry moment demands it.
"Davos for Digital Validation." Reinvention is not disruption. It is not innovation theater. It is the deliberate, disciplined reconstruction of how an organization makes decisions — at the system level, not the surface level.
On October 24, 2025, thirty-seven practitioners met at the NC Biotechnology Center in Research Triangle Park — five pharmaceutical companies, five vendor organizations, quality leaders, validation engineers, technology partners, and regulatory professionals. They named four systemic challenges, then wrote a shared thesis.
"We believe digital validation must be reinvented from the ground up to align assurance with real risk, accelerate value delivery, and make trust visible."
And any leader who has built a compliant quality system and still asks why the same problems keep recurring.
The Reinvention Lab Mini-Lab runs the morning of October 8 — Day 2 of KENX MedTech Validation University, co-located with GMP University. It is a condensed, hands-on session where participants apply the DQI Framework to their own organization's decision failures, with ProcellaRX facilitation. No product pitches. No passive audiences. Seats are limited.
